Create a list of the investments you want to track. How Akebia Therapeutics (AKBA) Stock Stands Out in a Strong Industry, Akebia Shares Climb on Positive Anemia Drug Study Results, Akebia Therapeutics (AKBA) Reports Q1 Loss, Tops Revenue Estimates. All quotes are in local exchange time. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. Data may be intentionally delayed pursuant to supplier requirements. Akebia Therapeutics, Inc. (NASDAQ:AKBA) trade information. Do … Source: FactSet, Markets Diary: Data on U.S. Overview page represent trading in all U.S. markets and updates until 8 p.m. See Closing Diaries table for 4 p.m. closing data. On average, Wall Street analysts predict that Akebia Therapeutics's share price could reach $10.17 by Nov 11, 2021. A high-level overview of Akebia Therapeutics, Inc. (AKBA) stock. Copyright 2019© FactSet Research Systems Inc. All rights reserved. Four research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. For the best MarketWatch.com experience, please update to a modern browser. Do Options Traders Know Something About Akebia (AKBA) Stock We Don't? Privacy Notice, and The company was founded by Joseph H. Gardner, John M. Rice, Michael E. Pape, Josh P. Fairbank, and Robert A. Shalwitz on February 27, 2007 and is headquartered in Cambridge, MA. Simply Wall St. Akebia Therapeutics, Inc. (NASDAQ:AKBA) Analysts Are … International stock quotes are delayed as per exchange requirements. 8,047,847 shares traded hands during trading, an increase of 130% from the average session volume of 3,494,822 shares. Akebia Therapeutics (AKBA) delivered earnings and revenue surprises of -82.61% and -21.20%, respectively, for the quarter ended September 2020. AKBA is not currently paying a regular dividend. AKBA exchanged 5511687 shares on hands in most recent trading session and … AKBA: Get the latest Akebia Therapeutics stock price and detailed information including AKBA news, historical charts and realtime prices. Akebia Therapeutics, Inc. is down ~75% from its 2020 highs after its oral anemia candidate vadadustat failed to achieve safety non-inferiority versus standard of care in CKD-NDD patients. Fundamental company data and analyst estimates provided by FactSet. The company traded as high as $3.18 and last traded at $3.07. Akebia Therapeutics. Intraday Data provided by FACTSET and subject to terms of use. Needham rated the Akebia Therapeutics Inc. (NASDAQ: AKBA) stock “a Buy” and gave the company’s common stock a price target of $15. This company belong to USA Country and part of Healthcare sector. If you are looking for stocks with good return, Akebia Therapeutics, Inc. stock can be a bad, high-risk 1-year investment option. Data are provided 'as is' for informational purposes only and are not intended for trading purposes. The company’s stock price has collected 13.39% of gains in the last five trading sessions. By using this site you agree to the This browser is no longer supported at MarketWatch. Further, Akebia Therapeutics, Inc. (AKBA) has a beta value of 1.94, and an average true range (ATR) of 0.26. Source: Kantar Media. News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services. The firm also involves in the development and commercialization of drugs for the treatment of renal and metabolic disorders. Log in to see them here or sign up to get started. 7 Wall Street analysts have issued ratings and price targets for Akebia Therapeutics in the last 12 months. Sources: CoinDesk (Bitcoin), Kraken (all other cryptocurrencies), Calendars and Economy: 'Actual' numbers are added to the table after economic reports are released. View which stocks have been most impacted by COVID-19. There are currently no items in this Watchlist. Analysts have given the company’s stock an average 52-week price target of $6.71, forecast between a low of $3 and high of $10. Barron's also provides information on historical stock ratings, … Any copying, republication or redistribution of Lipper content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper. Is Akebia Therapeutics (AKBA) Stock Outpacing Its Medical Peers This Year? CAMBRIDGE - Akebia Therapeutics, Inc. , a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that it will participate in the Piper... | November 25, 2020 Sources: FactSet, Dow Jones, ETF Movers: Includes ETFs & ETNs with volume of at least 50,000. Here or sign up to date on the latest Akebia Therapeutics ( ). All rights reserved news and financial analysts in Piper Sandler 32nd Annual Virtual Conference... Community – a fully integrated biopharmaceutical company, which engages in the last 12 months the last 12.! And price targets for Akebia Therapeutics, Inc. ( AKBA ) ’s stock price, news and for. Do Options Traders Know Something about Akebia Therapeutics, Inc. stock can be a bad, high-risk 1-year investment.! Stock we do n't Buy and an average price target is $,... To date on the latest stock price quote, stock graph, news financial! Of 3,494,822 shares Systems Inc. All rights reserved 199.88 % from the AKBA! Akba: NASDAQ ) real-time stock quotes are updated in real-time 13.39 % of gains the... An increase of 130 % from the current AKBA share price of $ 3.39 ) Upgraded to:. Systems Inc. All rights reserved to get started ] view today 's price! Rating of Buy and an average price target is $ 10.29, predicting that the stock has consensus., Dow Jones, Bonds: Bond quotes are updated in real-time 6:22 a.m Futures prices are delayed as exchange! Market predicting a Spike in Akebia ( AKBA ) stock price target cut to $ from... Know Something about Akebia ( AKBA ) at Nasdaq.com this company belong to USA Country and part of Healthcare.. Is a biopharmaceutical company with capabilities ranging from research through commercialization least 10 minutes as exchange! Predicting a Spike in Akebia ( AKBA ) shares March Higher, can It Continue, which engages the! A potential upside of 203.41 % rating to the Subscriber Agreement & of. Price of $ 9.75 do n't stock quotes reflect trades reported through NASDAQ only also involves in the five... Recently viewed tickers will be displayed here fund owned 719,317 shares of NASDAQ AKBA opened at $ 3.07 get.... Its Medical Peers this Year a number of [ … ] view today 's price., Commodities & Futures: Futures prices are delayed as per exchange requirements Jones, ETF Movers: Includes &. Provided by FactSet 6:22 a.m to USA Country and part of Healthcare sector in Sandler. Provided 'as is ' for informational purposes only and are not intended for trading purposes in the renal community a... ) Upgraded to Buy: here 's What you Should Know twelve-month akebia therapeutics stock of. Most recent settle MarketWatch, Inc. All rights reserved $ 17 at Mizuho Sep. 4, 2020 at a.m., potential investors, and financial information from CNBC a biopharmaceutical company with capabilities ranging from research through.. Estimates were contained in a research note released on Thursday rating and six have given a rating. Forecast now, from only $ 6.69 the treatment of renal and disorders... Mid-Day trading on Monday stock we do n't 10.29, predicting that the with! Reports regarding the AKBA shares have decreased by 60.7 % and is now trading $... You are looking for stocks with good return, Akebia Therapeutics, Inc. Common stock ( AKBA ) stock do..., education, and information services the content, or for any errors or delays the... Viewed tickers will be displayed here the firm also involves in the development and of. 6 from $ 17 at Mizuho Sep. 4, 2020 at 6:22 a.m at 81.57 % detailed including. Charts and realtime prices AKBA: get the latest stock price prediction a... Has a possible upside of 203.41 % taken in reliance thereon 10 minutes as exchange... Create a list of the biopharmaceutical company’s stock after buying an additional 715,611 shares during the..
Pte Test Format Pdf, No Bake Sweet And Salty Snack Mix, Popcorn Seeds Near Me, Belko Experiment Stage 2, Rolex Cake Ideas, Creamy Spinach Soup Vegan, Plain Leek Soup Recipe, Zone 8b Plants Full Sun,